{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-038637","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2026-08-17T12:15:29+00:00","discovered_at":"2026-08-17T12:20:03.563445+00:00","generated_at":"2026-08-17T12:20:23.416358+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NexGel Q2 2026: revenue $3.69M, net loss $2.87M; BioNX backlog $795K; proxy vote fails","bullets":["Q2 revenue $3.69M, net loss $2.87M; includes $756,554 BioNX amortization, $273,710 transaction costs, $144,495 SilverSeal recall.","BioNX Surgical backlog ~$795K due to supply chain; Sequence transferring manufacturing to San Antonio, TX.","Proxy vote failed to increase authorized shares/reverse split; will resolicit standalone, engaged Alliance Advisors, target late Sept.","$710K restricted cash from ATW Partners released and returned post-quarter; relationship concluded.","Launched BioNX Regenerative Eye Health & Aesthetics, led by Shaun Mullen; SilverSeal recall supports hospital launch in August."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-038637","json":"https://secwatch.observer/filing/0001493152-26-038637.json","markdown":"https://secwatch.observer/filing/0001493152-26-038637.md","text":"https://secwatch.observer/filing/0001493152-26-038637.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226038637/0001493152-26-038637-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226038637/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T12:20:23.416358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}